All the subjects received clinical assessment, anthropometric measurement, 75 g oral glucose tolerance test (OGTT), laboratory assays, and MRI examination at baseline and after 12 weeks monotherapy
These titration schedules balance achieving therapeutic levels with minimizing nausea, vomiting and other gastrointestinal effects that commonly occur when GLP 1 medications are started or increased too quickly
Key Characteristics High-purity research peptide Consistent formulation standards Documented quality controls Secure packaging Storage & Handling Store as directed in product documentation to maintain stability
Side effects can be significant enough that patients discontinue use of the meds, even when theyre seeing results
Management should follow standard GORD advice in line with NICE CG184, starting with dietary and lifestyle changes such as eating smaller meals, avoiding trigger foods, and not lying down after eating